Therapeutics
NeoTrofin
Quick Links
Overview
Name: NeoTrofin
Synonyms: AIT-082, leteprinim
Chemical Name: 4-{[3-(6-oxo-3,6-dihydro-9H-purin-9-yl)propanoyl]amino}benzoic acid
Therapy Type: Small Molecule (timeline)
Target Type: Unknown
Condition(s): Alzheimer's Disease
U.S. FDA Status: Alzheimer's Disease (Discontinued)
Company: NeoTherapeutics, Inc.
Approved for: None
Background
NeoTrofin is a derivative of the purine hypoxanthin. It was found to stimulate the production mRNA for NGF, neurotrophin-3, and bFGF in cultured mouse astrocytes (Glasky et al., 1995).
Last Updated: 09 Jan 2014
References
No Available References
Further Reading
No Available Further Reading
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.